In 2002, two big pharmaceutical companies took interest in male contraception, Schering and Organon.

2002年，两家大型制药公司——Schering 和 Organon——对男性避孕药产生了兴趣。

Narrator: According to Dr. Wang, male contraception was also too risky for Big Pharma at the time.

旁白: 根据王博士的说法, 当时男性避孕对大型制药公司来说风险太大。